Combination of Transcatheter Arterial Chemoembolization With Drug-eluting Beads, Lenvatinib and Anti-PD(L)1 Antibody for Downstaging Intrahepatic Cholangiocarcinoma for Radical Surgical Treatment
Latest Information Update: 28 Mar 2024
At a glance
- Drugs Atezolizumab (Primary) ; Camrelizumab (Primary) ; Doxorubicin (Primary) ; Durvalumab (Primary) ; Lenvatinib (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary) ; Sintilimab (Primary) ; Tislelizumab (Primary) ; Toripalimab (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- Acronyms CCGLC-009
Most Recent Events
- 10 Jan 2024 New trial record